- Qualcomm jumps on upbeat outlook, Nvidia soars
- Moderna tumbles on lower COVID-19 vaccine forecast
- Bank stocks slump as Treasury yields fall
Nov 4 (Reuters) – The S&P 500 and Nasdaq rose to record highs on Thursday as chipmaker stocks surged following Qualcomm’s (QCOM.O) strong financial forecast and investors digested the Federal Reserve’s decision to start reducing its monthly bond purchases.
Financials (.SPSY) dropped sharply as U.S. Treasury yields fell, with the market unwinding expectations of quicker Fed rate hikes a day after the central bank signaled it was in no hurry to do so. read more
“The growth side of the market is seeing more positive results today as they are benefiting from the falling yields that are developing," said Matthew Miskin, co-chief investment strategist at John Hancock Investment Management.
"The market had been positioning for higher yields in general given the Fed announcement of tapering. As we walked in today, there has been a reversal in that."
According to preliminary data, the S&P 500 (.SPX) gained 19.68 points, or 0.42%, to end at 4,680.25 points, while the Nasdaq Composite (.IXIC) gained 128.72 points, or 0.82%, to 15,941.05. The Dow Jones Industrial Average (.DJI) fell 31.14 points, or 0.09%, to 36,126.44.
Qualcomm shares jumped as the company forecast better-than-expected profits and revenue for its current quarter on soaring demand for chips used in phones, cars and other internet-connected devices. read more
Better-than-expected third-quarter earnings have helped lift sentiment for equities. With about 420 companies having reported, S&P 500 earnings are expected to have climbed 41.2% in the third quarter from a year earlier, according to Refinitiv IBES.
"The corporate earnings story remains quite bright," said Craig Fehr, investment strategist at Edward Jones.
"The market is rewarding companies that are beating and upping their outlook, and the market is punishing companies that are missing their estimates in the quarter and more importantly, perhaps, signaling a more sour outlook."
Moderna (MRNA.O) shares tumbled as the company slashed the 2021 sales forecast for its COVID-19 vaccine by as much as $5 billion, grappling to fill vials and distribute them to meet unprecedented world demand. Moderna shares weighed on the S&P 500 healthcare sector (.SPXHC)
Data showed the number of Americans filing new claims for unemployment benefits fell to the lowest level in nearly 20 months last week, suggesting the economy was regaining momentum. Investors will get a critical view of the economy with the monthly jobs report on Friday.
Our Standards: The Thomson Reuters Trust Principles.
- Nasdaq ends at record high as Wall Street rises with tech shares
- US STOCKS-Dow, S&P 500 end lower on fears over surging virus cases but Nasdaq hits record high
- Nasdaq sets another record high as tech stocks rally
- Record high median house prices again for Waikato
- Coronavirus live updates: Bay Area hospitalizations hit record high, deaths reported across region
- Market Movers: RIL at record highs ahead of AGM, TCS gains; 94 stocks give sell signals
- Coronavirus live updates: Bay Area hospitalizations reach another record high
- Iran cases hit record high in second wave of coronavirus
- Dow, S&P 500 fall on fears over virus resurgence but Nasdaq ends at record high
- Heat-trapping carbon dioxide in the atmosphere hits new record that experts say is the highest in several MILLION of years, despite emissions dropping due to the coronavirus pandemic
- Financials lift S&P 500, Dow despite record U.S. virus cases
- Sara Price hired by Chip Ganassi Racing as first driver in Extreme E
- Dow surges 500 points and stocks turn positive for 2020
- Rural boost lifts Escorts share price to new high
- Elon Musk is now richer than Warren Buffett as Tesla stock rockets 14% to an all-time high of $321billion and briefly becomes 10th largest US company by market value
- US STOCKS-S&P 500 rises as traders weigh stimulus and virus worries
- RPT-US STOCKS-S&P 500 ends higher as traders weigh stimulus and virus worries
- S&P 500 ends higher as traders weigh stimulus and virus worries
- Crowded trade, high valuations: why investors worry about tech stocks
- US STOCKS-S&P 500 scales over 4-month peak on vaccine hopes, Goldman profit beat
Chip, growth shares lift S&P 500, Nasdaq to record highs have 735 words, post on www.reuters.com at November 4, 2021. This is cached page on Europe Breaking News. If you want remove this page, please contact us.